Does the media favor LFST or TEM?

In the previous week, Tempus AI had 8 more articles in the media than LifeStance Health Group. MarketBeat recorded 11 mentions for Tempus AI and 3 mentions for LifeStance Health Group. Tempus AI's average media sentiment score of 0.70 beat LifeStance Health Group's score of 0.43 indicating that Tempus AI is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LifeStance Health Group 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Tempus AI 4 Very Positive mention(s) 3 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to LFST or FMS?

In the previous week, LifeStance Health Group and LifeStance Health Group both had 3 articles in the media. LifeStance Health Group's average media sentiment score of 0.43 beat Fresenius Medical Care AG & Co. KGaA's score of 0.34 indicating that LifeStance Health Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LifeStance Health Group 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Fresenius Medical Care AG & Co. KGaA 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to LFST or DVA?

In the previous week, LifeStance Health Group had 1 more articles in the media than DaVita. MarketBeat recorded 3 mentions for LifeStance Health Group and 2 mentions for DaVita. LifeStance Health Group's average media sentiment score of 0.43 beat DaVita's score of 0.00 indicating that LifeStance Health Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LifeStance Health Group 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral DaVita 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor LFST or HNGE?

In the previous week, Hinge Health had 6 more articles in the media than LifeStance Health Group. MarketBeat recorded 9 mentions for Hinge Health and 3 mentions for LifeStance Health Group. Hinge Health's average media sentiment score of 0.59 beat LifeStance Health Group's score of 0.43 indicating that Hinge Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LifeStance Health Group 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Hinge Health 2 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

LifeStance Health Group (LFST) Competitors

$11.83 -0.08 (-0.67%)

Closing price 10/2/2026 04:00 PM Eastern

Extended Trading

$11.75 -0.08 (-0.68%)

As of 10/2/2026 07:30 PM Eastern

Compare

LFST vs. TEM, FMS, DVA, BTSG, and HNGE

Should you buy LifeStance Health Group stock or one of its competitors? LifeStance Health Group's main competitors and comparable companies include Tempus AI (TEM), Fresenius Medical Care AG & Co. KGaA (FMS), DaVita (DVA), BrightSpring Health Services (BTSG), and Hinge Health (HNGE). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does LifeStance Health Group compare to Tempus AI?

LifeStance Health Group (NASDAQ:LFST) and Tempus AI (NASDAQ:TEM) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, profitability, earnings, analyst recommendations, media sentiment, institutional ownership, dividends and valuation.

LifeStance Health Group has a beta of 1.24, meaning that its share price is 24% more volatile than the broader market. Comparatively, Tempus AI has a beta of 3.54, meaning that its share price is 254% more volatile than the broader market.

85.5% of LifeStance Health Group shares are owned by institutional investors. Comparatively, 24.2% of Tempus AI shares are owned by institutional investors. 3.5% of LifeStance Health Group shares are owned by company insiders. Comparatively, 24.3% of Tempus AI shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

LifeStance Health Group has higher revenue and earnings than Tempus AI. Tempus AI is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LifeStance Health Group	$1.42B	3.17	$9.66M	$0.13	91.00
Tempus AI	$1.27B	10.87	-$245.03M	-$1.44	N/A

In the previous week, Tempus AI had 8 more articles in the media than LifeStance Health Group. MarketBeat recorded 11 mentions for Tempus AI and 3 mentions for LifeStance Health Group. Tempus AI's average media sentiment score of 0.70 beat LifeStance Health Group's score of 0.43 indicating that Tempus AI is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LifeStance Health Group	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Tempus AI	4 Very Positive mention(s)	3 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

LifeStance Health Group currently has a consensus price target of $12.88, suggesting a potential upside of 8.83%. Tempus AI has a consensus price target of $71.05, suggesting a potential downside of 7.28%. Given LifeStance Health Group's stronger consensus rating and higher possible upside, analysts clearly believe LifeStance Health Group is more favorable than Tempus AI.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LifeStance Health Group	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.73
Tempus AI	2 Sell rating(s)	9 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.41

LifeStance Health Group has a net margin of 3.19% compared to Tempus AI's net margin of -17.77%. LifeStance Health Group's return on equity of 3.39% beat Tempus AI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LifeStance Health Group	3.19%	3.39%	2.33%
Tempus AI	-17.77%	-50.28%	-10.33%

Summary

LifeStance Health Group beats Tempus AI on 11 of the 17 factors compared between the two stocks.

How does LifeStance Health Group compare to Fresenius Medical Care AG & Co. KGaA?

LifeStance Health Group (NASDAQ:LFST) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, valuation, earnings, profitability, dividends, risk, analyst recommendations and institutional ownership.

In the previous week, LifeStance Health Group and LifeStance Health Group both had 3 articles in the media. LifeStance Health Group's average media sentiment score of 0.43 beat Fresenius Medical Care AG & Co. KGaA's score of 0.34 indicating that LifeStance Health Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LifeStance Health Group	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Fresenius Medical Care AG & Co. KGaA	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

LifeStance Health Group presently has a consensus target price of $12.88, indicating a potential upside of 8.83%. Fresenius Medical Care AG & Co. KGaA has a consensus target price of $23.68, indicating a potential upside of 6.29%. Given LifeStance Health Group's stronger consensus rating and higher probable upside, equities research analysts plainly believe LifeStance Health Group is more favorable than Fresenius Medical Care AG & Co. KGaA.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LifeStance Health Group	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.73
Fresenius Medical Care AG & Co. KGaA	5 Sell rating(s)	7 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.58

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.83% compared to LifeStance Health Group's net margin of 3.19%. Fresenius Medical Care AG & Co. KGaA's return on equity of 9.28% beat LifeStance Health Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LifeStance Health Group	3.19%	3.39%	2.33%
Fresenius Medical Care AG & Co. KGaA	4.83%	9.28%	4.16%

LifeStance Health Group has a beta of 1.24, meaning that its stock price is 24% more volatile than the broader market. Comparatively, Fresenius Medical Care AG & Co. KGaA has a beta of 0.74, meaning that its stock price is 26% less volatile than the broader market.

85.5% of LifeStance Health Group shares are held by institutional investors. Comparatively, 8.4% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. 3.5% of LifeStance Health Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than LifeStance Health Group. Fresenius Medical Care AG & Co. KGaA is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LifeStance Health Group	$1.42B	3.17	$9.66M	$0.13	91.00
Fresenius Medical Care AG & Co. KGaA	$22.20B	0.54	$1.11B	$1.93	11.54

Summary

LifeStance Health Group beats Fresenius Medical Care AG & Co. KGaA on 10 of the 16 factors compared between the two stocks.

How does LifeStance Health Group compare to DaVita?

LifeStance Health Group (NASDAQ:LFST) and DaVita (NYSE:DVA) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, earnings, institutional ownership, dividends, valuation, risk and media sentiment.

LifeStance Health Group has a beta of 1.24, meaning that its stock price is 24% more volatile than the broader market. Comparatively, DaVita has a beta of 0.8, meaning that its stock price is 20% less volatile than the broader market.

DaVita has higher revenue and earnings than LifeStance Health Group. DaVita is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LifeStance Health Group	$1.42B	3.17	$9.66M	$0.13	91.00
DaVita	$13.64B	0.84	$746.80M	$12.22	14.62

In the previous week, LifeStance Health Group had 1 more articles in the media than DaVita. MarketBeat recorded 3 mentions for LifeStance Health Group and 2 mentions for DaVita. LifeStance Health Group's average media sentiment score of 0.43 beat DaVita's score of 0.00 indicating that LifeStance Health Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LifeStance Health Group	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
DaVita	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

LifeStance Health Group presently has a consensus target price of $12.88, suggesting a potential upside of 8.83%. DaVita has a consensus target price of $233.43, suggesting a potential upside of 30.66%. Given DaVita's higher possible upside, analysts plainly believe DaVita is more favorable than LifeStance Health Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LifeStance Health Group	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.73
DaVita	0 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.43

DaVita has a net margin of 6.05% compared to LifeStance Health Group's net margin of 3.19%. LifeStance Health Group's return on equity of 3.39% beat DaVita's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LifeStance Health Group	3.19%	3.39%	2.33%
DaVita	6.05%	-217.63%	5.07%

85.5% of LifeStance Health Group shares are held by institutional investors. Comparatively, 90.1% of DaVita shares are held by institutional investors. 3.5% of LifeStance Health Group shares are held by company insiders. Comparatively, 1.9% of DaVita shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

LifeStance Health Group beats DaVita on 10 of the 17 factors compared between the two stocks.

How does LifeStance Health Group compare to BrightSpring Health Services?

BrightSpring Health Services (NASDAQ:BTSG) and LifeStance Health Group (NASDAQ:LFST) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, earnings, institutional ownership, profitability, media sentiment and dividends.

LifeStance Health Group has a net margin of 3.19% compared to BrightSpring Health Services' net margin of 2.55%. BrightSpring Health Services' return on equity of 16.73% beat LifeStance Health Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BrightSpring Health Services	2.55%	16.73%	5.24%
LifeStance Health Group	3.19%	3.39%	2.33%

BrightSpring Health Services has higher revenue and earnings than LifeStance Health Group. BrightSpring Health Services is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BrightSpring Health Services	$12.91B	0.92	$190.67M	$1.66	36.30
LifeStance Health Group	$1.42B	3.17	$9.66M	$0.13	91.00

BrightSpring Health Services has a beta of 1.87, suggesting that its stock price is 87% more volatile than the broader market. Comparatively, LifeStance Health Group has a beta of 1.24, suggesting that its stock price is 24% more volatile than the broader market.

In the previous week, BrightSpring Health Services had 1 more articles in the media than LifeStance Health Group. MarketBeat recorded 4 mentions for BrightSpring Health Services and 3 mentions for LifeStance Health Group. BrightSpring Health Services' average media sentiment score of 0.84 beat LifeStance Health Group's score of 0.43 indicating that BrightSpring Health Services is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
BrightSpring Health Services	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
LifeStance Health Group	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

85.5% of LifeStance Health Group shares are held by institutional investors. 2.8% of BrightSpring Health Services shares are held by company insiders. Comparatively, 3.5% of LifeStance Health Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

BrightSpring Health Services presently has a consensus target price of $70.71, suggesting a potential upside of 17.35%. LifeStance Health Group has a consensus target price of $12.88, suggesting a potential upside of 8.83%. Given BrightSpring Health Services' stronger consensus rating and higher possible upside, equities analysts clearly believe BrightSpring Health Services is more favorable than LifeStance Health Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BrightSpring Health Services	0 Sell rating(s)	0 Hold rating(s)	18 Buy rating(s)	2 Strong Buy rating(s)	3.10
LifeStance Health Group	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.73

Summary

BrightSpring Health Services beats LifeStance Health Group on 12 of the 17 factors compared between the two stocks.

How does LifeStance Health Group compare to Hinge Health?

LifeStance Health Group (NASDAQ:LFST) and Hinge Health (NYSE:HNGE) are both mid-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, earnings, dividends, valuation, institutional ownership, profitability and risk.

85.5% of LifeStance Health Group shares are held by institutional investors. 3.5% of LifeStance Health Group shares are held by insiders. Comparatively, 18.9% of Hinge Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

LifeStance Health Group currently has a consensus price target of $12.88, suggesting a potential upside of 8.83%. Hinge Health has a consensus price target of $105.33, suggesting a potential upside of 7.92%. Given LifeStance Health Group's higher probable upside, equities research analysts plainly believe LifeStance Health Group is more favorable than Hinge Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LifeStance Health Group	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.73
Hinge Health	0 Sell rating(s)	3 Hold rating(s)	15 Buy rating(s)	1 Strong Buy rating(s)	2.89

LifeStance Health Group has higher revenue and earnings than Hinge Health. Hinge Health is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LifeStance Health Group	$1.42B	3.17	$9.66M	$0.13	91.00
Hinge Health	$587.86M	13.40	-$528.26M	$1.28	76.25

In the previous week, Hinge Health had 6 more articles in the media than LifeStance Health Group. MarketBeat recorded 9 mentions for Hinge Health and 3 mentions for LifeStance Health Group. Hinge Health's average media sentiment score of 0.59 beat LifeStance Health Group's score of 0.43 indicating that Hinge Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LifeStance Health Group	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Hinge Health	2 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Hinge Health has a net margin of 15.15% compared to LifeStance Health Group's net margin of 3.19%. Hinge Health's return on equity of 51.60% beat LifeStance Health Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LifeStance Health Group	3.19%	3.39%	2.33%
Hinge Health	15.15%	51.60%	14.16%

LifeStance Health Group has a beta of 1.24, suggesting that its share price is 24% more volatile than the broader market. Comparatively, Hinge Health has a beta of 1.37, suggesting that its share price is 37% more volatile than the broader market.

Summary

Hinge Health beats LifeStance Health Group on 11 of the 16 factors compared between the two stocks.

Get LifeStance Health Group News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LFST and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

LFST vs. The Competition

Export

Metric	LifeStance Health Group	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$4.52B	$9.68B	$7.15B	$13.28B
Dividend Yield	N/A	2.61%	2.54%	17.33%
P/E Ratio	91.01	34.21	275.67	26.04
Price / Sales	3.17	4.87	656.66	111.05
Price / Cash	70.33	120.59	78.87	52.62
Price / Book	3.03	5.15	10.93	6.31
Net Income	$9.66M	$315.68M	$3.51B	$362.16M
7 Day Performance	-0.08%	-2.59%	-2.00%	-1.66%
1 Month Performance	-7.07%	-3.07%	-6.19%	-4.68%
1 Year Performance	114.70%	7.86%	8.03%	1.57%

LifeStance Health Group Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
LFST LifeStance Health Group	3.6505 of 5 stars	$11.83 -0.7%	$12.88 +8.8%	+114.7%	$4.52B	$1.42B	91.01	10,961
TEM Tempus AI	1.7925 of 5 stars	$82.58 -2.9%	$69.63 -15.7%	-16.4%	$14.90B	$1.27B	N/A	3,800	Analyst Forecast
FMS Fresenius Medical Care AG & Co. KGaA	3.0862 of 5 stars	$22.27 -3.0%	$23.68 +6.3%	-16.7%	$11.96B	$22.20B	11.54	1,488	Analyst Downgrade
DVA DaVita	4.565 of 5 stars	$175.00 -1.7%	$233.43 +33.4%	+36.3%	$11.16B	$13.64B	14.32	78,000
BTSG BrightSpring Health Services	4.361 of 5 stars	$55.69 -1.5%	$70.71 +27.0%	+112.4%	$11.02B	$12.91B	33.55	23,500	Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:LFST) was last updated on 10/4/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

LifeStance Health Group (LFST) Competitors

LFST vs. TEM, FMS, DVA, BTSG, and HNGE

How does LifeStance Health Group compare to Tempus AI?

Summary

How does LifeStance Health Group compare to Fresenius Medical Care AG & Co. KGaA?

Summary

How does LifeStance Health Group compare to DaVita?

Summary

How does LifeStance Health Group compare to BrightSpring Health Services?

Summary

How does LifeStance Health Group compare to Hinge Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

LFST vs. The Competition

LifeStance Health Group Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

LifeStance Health Group (LFST) Competitors

LFST vs. TEM, FMS, DVA, BTSG, and HNGE

How does LifeStance Health Group compare to Tempus AI?

Which has more volatility & risk, LFST or TEM?

Do institutionals & insiders hold more shares of LFST or TEM?

Which has preferable earnings & valuation, LFST or TEM?

Does the media favor LFST or TEM?

Do analysts recommend LFST or TEM?

Is LFST or TEM more profitable?

Summary

How does LifeStance Health Group compare to Fresenius Medical Care AG & Co. KGaA?

Does the media refer more to LFST or FMS?

Do analysts recommend LFST or FMS?

Is LFST or FMS more profitable?

Which has more risk & volatility, LFST or FMS?

Do institutionals & insiders have more ownership in LFST or FMS?

Which has higher valuation & earnings, LFST or FMS?

Summary

How does LifeStance Health Group compare to DaVita?

Which has more volatility & risk, LFST or DVA?

Which has preferable earnings & valuation, LFST or DVA?

Does the media refer more to LFST or DVA?

Do analysts recommend LFST or DVA?

Is LFST or DVA more profitable?

Do institutionals & insiders hold more shares of LFST or DVA?

Summary

How does LifeStance Health Group compare to BrightSpring Health Services?

Is BTSG or LFST more profitable?

Which has higher earnings & valuation, BTSG or LFST?

Which has more volatility and risk, BTSG or LFST?

Does the media favor BTSG or LFST?

Do institutionals and insiders hold more shares of BTSG or LFST?

Do analysts recommend BTSG or LFST?

Summary

How does LifeStance Health Group compare to Hinge Health?

Do institutionals & insiders hold more shares of LFST or HNGE?

Do analysts prefer LFST or HNGE?

Which has preferable valuation & earnings, LFST or HNGE?

Does the media favor LFST or HNGE?

Is LFST or HNGE more profitable?

Which has more risk & volatility, LFST or HNGE?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

LFST vs. The Competition

LifeStance Health Group Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools